Home > Quotes > SNDX

Syndax Pharmaceuticals, Inc. Common Stock Quote & Summary Data

Get SNDX Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading SNDX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Syndax Pharmaceuticals, Inc. Common Stock Intraday Chart

News for SNDX

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 14 $ 17.49
Low $ 13.6601 $ 10.60

The current last sale of $13.69 is 29.15% Higher thanthe 52 week low.

Company Description (as filed with the SEC)

We are a clinical stage biopharmaceutical company developing entinostat as a combination therapy in multiple cancer indications with our initial focus on tumors that have shown sensitivity to immunotherapy, including lung cancer, melanoma, ovarian cancer and triple negative breast cancer, or TNBC. Entinostat is our oral, small molecule drug candidate that has direct effects on both cancer cells and immune regulatory cells, potentially enhancing the body's immune response to tumors. The favorable safety profile of entinostat has been demonstrated in clinical trials in more than 900 cancer patients.  ... More ...  

Risk Grade

Where does SNDX fit in the risk graph?

Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?